Alzheimers Disease

Showing 1 - 21 of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimers Disease Trial in Worldwide (Semaglutide, Placebo)

Not yet recruiting
  • Alzheimers Disease
  • Sun City, Arizona
  • +8 more
May 29, 2023

Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Matching Placebo (Gantenerumab))

Suspended
  • Alzheimers Disease
  • +2 more
  • Birmingham, Alabama
  • +34 more
Jan 10, 2023

Alzheimers Disease Trial in Worldwide (RO7126209, Placebo)

Recruiting
  • Alzheimers Disease
  • Atlantis, Florida
  • +13 more
Aug 12, 2022

Aducanumab-avwa in Alzheimer's Disease in the US

Terminated
  • Alzheimers Disease
    • Chula Vista, California
    • +21 more
    Jun 16, 2022

    Alzheimers Disease Trial in Raleigh (RO7126209, Placebo)

    Completed
    • Alzheimers Disease
    • Raleigh, North Carolina
      PRA Health Sciences
    Jul 15, 2021

    Alzheimers Disease Trial in Worldwide (CNP520 50mg, CNP520 15mg, Matching )

    Terminated
    • Alzheimers Disease
    • CNP520 50mg
    • +2 more
    • Phoenix, Arizona
    • +193 more
    Aug 4, 2021

    Alzheimers Disease Trial in Worldwide (biological, other, drug)

    Terminated
    • Alzheimers Disease
    • CAD106 Immunotherapy
    • +4 more
    • Phoenix, Arizona
    • +128 more
    Jul 7, 2021

    Alzheimers Disease, Postoperative Delirium, Post Operative Cognitive Dysfunction Trial in Durham (Total intravenous anesthesia

    Completed
    • Alzheimers Disease
    • +2 more
    • Total intravenous anesthesia with propofol
    • General anesthesia with isoflurane
    • Durham, North Carolina
      Duke University Medical Center
    May 4, 2020

    Alzheimers Disease Trial in New Haven (123-I MNI-187 Injection and Imaging Procedures)

    Completed
    • Alzheimers Disease
    • 123-I MNI-187 Injection and Imaging Procedures
    • New Haven, Connecticut
      Institute for Neurodegenerative Disorders
    Mar 12, 2019

    Alzheimers Disease and Neuromarkers in Acute Hip Fractures

    Completed
    • Alzheimers Disease
    • +2 more
      • Molndal, Vastra Gotaland, Sweden
        Sahlgrenska University Hospital
      Apr 25, 2017

      Bank of Biospecimens for Future Research on Age-related

      Completed
      • Dementia
      • Alzheimers Disease
        • Royal Oak, Michigan
          Beaumont Hospital
        Nov 3, 2016

        Alzheimers Disease Trial in Philadelphia (Florbetapir F18)

        Completed
        • Alzheimers Disease
        • Florbetapir F18
        • Philadelphia, Pennsylvania
          Research Site
        Jun 1, 2015

        Multiple Nutritional Deficiencies Causing Dementia of Alzheimer

        Unknown status
        • Mild Cognitive Impairment
        • Alzheimers Disease
          • Oslo, Norway
            OsloUH, UllevÄl
          Nov 26, 2013

          Alzheimers Disease Trial in Irvine, Los Angeles ([F18] T808)

          Terminated
          • Alzheimers Disease
          • [F18] T808
          • Irvine, California
          • +1 more
          Jul 18, 2013

          Alzheimers Disease, AD Trial in Irvine, Los Angeles ([F18] T807)

          Terminated
          • Alzheimers Disease
          • AD
          • [F18] T807
          • Irvine, California
          • +1 more
          Jul 18, 2013

          Alzheimers Disease Trial in Aarhus (Liraglutide, non-active study drug)

          Completed
          • Alzheimers Disease
          • Aarhus, Denmark
            Aarhus University
          Apr 18, 2013

          Non-expensive and Widely Available Tests as Diagnostic Tools in

          Unknown status
          • Alzheimers Disease
          • Mild Cognitive Impairment
            • Roskilde, Denmark
              Neurologisk Afd, Roskilde Sygehus
            Sep 12, 2012

            Alzheimers Disease Trial in New Haven ([123-I] AV-83 Injection and Imaging Procedures)

            Completed
            • Alzheimers Disease
            • [123-I] AV-83 Injection and Imaging Procedures
            • New Haven, Connecticut
              Molecular NeuroImaging
            May 9, 2008

            Alzheimers Disease Trial in New Haven ([123I] AV 39)

            Completed
            • Alzheimers Disease
            • [123I] AV 39
            • New Haven, Connecticut
              Molecular NeuroImaging, LLC
            Apr 22, 2008